H. Hanaire

4.5k total citations · 1 hit paper
94 papers, 2.6k citations indexed

About

H. Hanaire is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Genetics. According to data from OpenAlex, H. Hanaire has authored 94 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 74 papers in Endocrinology, Diabetes and Metabolism, 45 papers in Surgery and 18 papers in Genetics. Recurrent topics in H. Hanaire's work include Diabetes Management and Research (58 papers), Diabetes Treatment and Management (45 papers) and Pancreatic function and diabetes (25 papers). H. Hanaire is often cited by papers focused on Diabetes Management and Research (58 papers), Diabetes Treatment and Management (45 papers) and Pancreatic function and diabetes (25 papers). H. Hanaire collaborates with scholars based in France, United Kingdom and Germany. H. Hanaire's co-authors include Jean‐Pierre Riveline, Norbert Hermanns, Ramzi Ajjan, Thomas Haak, Gerry Rayman, Bruno Guerci, Patrick Ritz, C. Sanz, Éric Renard and N. Jeandidier and has published in prestigious journals such as Neurology, Diabetes Care and Diabetes.

In The Last Decade

H. Hanaire

90 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial

2016 441 citations Thomas Haak, H. Hanaire et al. Diabetes Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
H. Hanaire France	29	1.9k	1.2k	812	373	203	94	2.6k
Howard Wolpert United States	29	3.1k 1.7×	1.5k 1.2×	1.4k 1.8×	309 0.8×	282 1.4×	63	4.0k
Klaus Jeitler Austria	20	1.2k 0.7×	718 0.6×	408 0.5×	321 0.9×	131 0.6×	47	2.2k
Thomas Haak Germany	26	2.0k 1.1×	588 0.5×	641 0.8×	247 0.7×	292 1.4×	112	2.8k
Hood Thabit United Kingdom	31	2.7k 1.5×	1.9k 1.5×	1.6k 1.9×	205 0.5×	205 1.0×	97	3.4k
Roger S. Mazze United States	23	1.5k 0.8×	644 0.5×	351 0.4×	211 0.6×	228 1.1×	68	2.2k
Kristin Castorino United States	15	1.2k 0.7×	474 0.4×	343 0.4×	842 2.3×	288 1.4×	38	2.4k
Julie Edge United Kingdom	29	2.3k 1.2×	1.2k 0.9×	1.9k 2.3×	479 1.3×	89 0.4×	67	3.3k
Virginie Messier Canada	27	1.4k 0.8×	992 0.8×	651 0.8×	990 2.7×	103 0.5×	78	2.7k
Eda Cengiz United States	28	2.4k 1.3×	1.6k 1.3×	1.4k 1.7×	146 0.4×	97 0.5×	79	2.8k
Lalantha Leelarathna United Kingdom	33	2.5k 1.3×	1.7k 1.3×	1.4k 1.8×	91 0.2×	162 0.8×	91	2.8k

Countries citing papers authored by H. Hanaire

Since Specialization

Citations

This map shows the geographic impact of H. Hanaire's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Hanaire with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Hanaire more than expected).

Fields of papers citing papers by H. Hanaire

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Hanaire. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Hanaire. The network helps show where H. Hanaire may publish in the future.

Co-authorship network of co-authors of H. Hanaire

This figure shows the co-authorship network connecting the top 25 collaborators of H. Hanaire. A scholar is included among the top collaborators of H. Hanaire based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Hanaire. H. Hanaire is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Hanaire, H., Richard F. Pollock, Neesha Nanu, et al.. (2025). Cost-Utility Analysis of the MiniMed ™ 780G Advanced Hybrid Closed-Loop System Versus Intermittently Scanned Continuous Glucose Monitoring with Multiple Daily Insulin Injections in People with Type 1 Diabetes in France. Diabetes Technology & Therapeutics. 27(10). 768–777.

2.

Aguayo, Gloria, Emmanuel Cosson, Éric Renard, et al.. (2025). Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort. BMJ Open Diabetes Research & Care. 13(1). e004524–e004524. 1 indexed citations

3.

Reznik, Yves, Gaëtan Prévost, Lucy Chaillous, et al.. (2023). Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed‐loop? The CLOSE AP + randomized controlled trial. Diabetes Obesity and Metabolism. 26(2). 622–630. 9 indexed citations

4.

Mathiesen, Elisabeth R., Norsiah Ali, Amra Ciric Alibegovic, et al.. (2021). Risk of Major Congenital Malformations or Perinatal or Neonatal Death With Insulin Detemir Versus Other Basal Insulins in Pregnant Women With Preexisting Diabetes: The Real-World EVOLVE Study. Diabetes Care. 44(9). 2069–2077. 17 indexed citations

5.

Franc, Sylvia, H. Hanaire, Pierre‐Yves Benhamou, et al.. (2020). DIABEO System Combining a Mobile App Software With and Without Telemonitoring Versus Standard Care: A Randomized Controlled Trial in Diabetes Patients Poorly Controlled with a Basal-Bolus Insulin Regimen. Diabetes Technology & Therapeutics. 22(12). 904–911. 20 indexed citations

6.

Lapeyre‐Mestre, Maryse, et al.. (2020). Diabetes Remission and Relapse After Bariatric Surgery: a Nationwide Population-Based Study. Obesity Surgery. 30(12). 4810–4820. 13 indexed citations

7.

Jeandidier, N., Lucy Chaillous, Sylvia Franc, et al.. (2018). DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Research Protocols. 7(4). e66–e66. 13 indexed citations

8.

Borel, Anne‐Laure, Renaud Tamisier, P. Böhme, et al.. (2018). Republication de : Prise en charge du syndrome d’apnées obstructives du sommeil chez la personne vivant avec un diabète : contexte, dépistage, indications et modalités de traitement. Position de la Société Francophone du Diabète (SFD), de la Société Française de Recherche et Médecine du Sommeil (SFRMS) et de la Société de Pneumologie de Langue Française (SPLF). Revue des Maladies Respiratoires. 35(10). 1067–1089. 2 indexed citations

9.

Wargny, Matthieu, Adeline Gallini, H. Hanaire, et al.. (2018). Diabetes Care and Dementia Among Older Adults: A Nationwide 3-Year Longitudinal Study. Journal of the American Medical Directors Association. 19(7). 601–606.e2. 10 indexed citations

10.

Haak, Thomas, H. Hanaire, Ramzi Ajjan, et al.. (2016). Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicenter, Open-Label Randomized Controlled Trial. Diabetes Therapy. 8(1). 55–73. 441 indexed citations breakdown →

11.

Hanaire, H., C. Attali, D. Gouet, et al.. (2016). [Determinants of the cost of initiation of insulin therapy type 2 diabetic patients in France: possible approaches to optimization].. PubMed. 28(6). 781–789. 4 indexed citations

12.

Reichardt, François, Céline Garret, Aurélie Waget, et al.. (2015). Autonomic Diabetic Neuropathy Impairs Glucose and Dipeptidyl Peptidase 4 Inhibitor-Regulated Glucagon Concentration in Type 1 Diabetic Patients. Journal of Endocrinology and Metabolism. 5(4). 229–237. 2 indexed citations

13.

Reichardt, François, Céline Garret, Aurélie Waget, et al.. (2015). Autonomic Diabetic Neuropathy Impairs Glucose and Dipeptidyl Peptidase 4 Inhibitor-Regulated Glucagon Concentration in Type 1 Diabetic Patients. Journal of Endocrinology and Metabolism. 5(4). 229–237. 4 indexed citations

14.

Schaepelynck, Pauline, Éric Renard, H. Hanaire, et al.. (2014). Assessment of a New Insulin Preparation for Implanted Pumps Used in the Treatment of Type 1 Diabetes. Diabetes Technology & Therapeutics. 16(9). 582–589. 9 indexed citations

15.

Ritz, Patrick, et al.. (2012). Usefulness of Acarbose and Dietary Modifications to Limit Glycemic Variability Following Roux-en-Y Gastric Bypass as Assessed by Continuous Glucose Monitoring. Diabetes Technology & Therapeutics. 14(8). 736–740. 48 indexed citations

16.

Lassmann‐Vague, V., S. Clavel, Bruno Guerci, et al.. (2010). When to treat a diabetic patient using an external insulin pump. Expert consensus. Société francophone du diabète (ex ALFEDIAM) 2009. Diabetes & Metabolism. 36(1). 79–85. 39 indexed citations

17.

Sanz, C., Jean–François Gautier, & H. Hanaire. (2010). Physical exercise for the prevention and treatment of type 2 diabetes. Diabetes & Metabolism. 36(5). 346–351. 99 indexed citations

18.

Nasr, Nathalie, et al.. (2010). Autonomic neuropathy is associated with impairment of dynamic cerebral autoregulation in type 1 diabetes. Autonomic Neuroscience. 160(1-2). 59–63. 10 indexed citations

19.

Traon, Anne Pavy‐Le, et al.. (2010). Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clinical Autonomic Research. 20(3). 153–160. 50 indexed citations

20.

Benhamou, Pierre‐Yves, V. Melki, R. Boizel, et al.. (2007). One-year efficacy and safety of Web-based follow-up using cellular phone in type 1 diabetic patients under insulin pump therapy: the PumpNet study. Diabetes & Metabolism. 33(3). 220–226. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact